Oaktree Acquisition Corp. III Life Sciences - COMMON-STOCK (OACC)

CUSIP: G6717R104

Q1 2025 13F Holders as of 31 Mar 2025

Security type / class
Equity / COMMON-STOCK
Total 13F shares
14,996,124
Total 13F value
$153,193,850
Holder snapshot 6 signals
Share change
+6,006,088
SEC-reported price per share
$10.23
Number of holders
39
Value change
+$61,471,490
Number of buys
26
Number of sells
11
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
19,807,471

Security key

G6717R104

Report period

Q1 2025

Institutions

39

Top holders

10

OACC full security history Ownership snapshot Full 13F holder table Newer quarter: Q3 2025 Oaktree Acquisition Corp. III Life Sciences SEC filings Oaktree Acquisition Corp. III Life Sciences company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of OACC - Oaktree Acquisition Corp. III Life Sciences - COMMON-STOCK (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Oaktree Acquisition Holdi...
Disclosed value leader
Oaktree Acquisition Holdi...
Comparable rows
14/15
Latest evidence
31 Mar 2025
13D/G 3/4/5 13F Lead comparable stake: 22% 1 rows are not safely comparable across share classes. 13D/G row: Oaktree Acquisition Holdings III LS, LLC Showing 1-6 of 15 holder rows.

Quick read

Oaktree Acquisition Holdings III LS, LLC leads the comparable SEC ownership view at 22%.

14 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Oaktree Acquisition Holdings III LS, LLC's linked filing trail.
Comparable ownership Top 5
Oaktree Acquisition Holdings III ... 22%
AQR CAPITAL MANAGEMENT LLC 7.3%
HEALTHCARE OF ONTARIO PENSION PLA... 3.5%
TORONTO DOMINION BANK 7.3%
Boussard & Gavaudan Investment Ma... 3.8%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Oaktree Acquisition Holdings III LS, LLC
13D/G 3/4/5
10%+ Owner
13D/G 3/4/5
22%
$56,160,462
5,500,535 shares
 $0 31 Dec 2024
AQR CAPITAL MANAGEMENT LLC
13D/G
13D/G
7.3%
$14,812,158
1,450,750 shares
 $0 31 Mar 2025
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND
13F 13D/G
Company
13F 13D/G
3.5%
from 13D/G
$17,255,000
1,700,000 shares
 — 31 Dec 2024
TORONTO DOMINION BANK
13F
Company
13F
7.3%
$14,354,631
1,436,900 shares
 — 31 Dec 2024
Boussard & Gavaudan Investment Management LLP
13F
Company
13F
3.8%
$7,597,500
750,000 shares
 — 31 Dec 2024
HIGHBRIDGE CAPITAL MANAGEMENT LLC
13F
Company
13F
2.3%
$4,495,500
450,000 shares
 — 31 Dec 2024
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
39
Shares
14,996,124
Rows available
39
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2025 vs Q1 2026 Across Filers

Q1 2026 holders
51
Q1 2025 holders
39
Holder diff
-12
Investor Q1 2026 Shares Q1 2025 Shares Share Diff Share Chg % Q1 2026 value Q1 2025 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .